Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 2, 2017, Pages

  van Agteren, Joseph Em ^a   Hnin, Khin ^b   Grosser, Dion ^c   Carson, Kristin V ^d   Smith, Brian J ^d  

^a Centre for Inflammatory Disease Research (CIDR)   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

^c QUEEN ELIZABETH HOSPITAL   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

SEALANT;

ABLATION THERAPY; AIRWAY BYPASS STENT; BLEEDING; BRONCHOSCOPIC LUNG VOLUME REDUCTION PROCEDURE; BRONCHOSCOPIC THERMAL VAPOR ABLATION; BRONCHOSCOPY; BRONCHOSPASM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EFFECTIVENESS; COLLATERAL VENTILATION; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; EMERGENCY CARE; EMPHYSEMA; ENDOBRONCHIAL COIL; ENDOBRONCHIAL VALVE; EXERCISE; FOLLOW UP; FORCED EXPIRATORY VOLUME; GAS DIFFUSION; HOSPITAL READMISSION; HOSPITAL UTILIZATION; HUMAN; INTRABRONCHIAL VALVE; LENGTH OF STAY; LOWER RESPIRATORY TRACT INFECTION; LUNG VENTILATION; MEDICAL CARE; OUTCOME ASSESSMENT; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PNEUMONIA; PNEUMOTHORAX; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESIDUAL VOLUME; RESPIRATORY FAILURE; RESPIRATORY THERAPEUTIC DEVICE; REVIEW; SELECTION BIAS; ST. GEORGE RESPIRATORY QUESTIONNAIRE; STENT; SURGICAL MORTALITY; SYSTEMATIC REVIEW; THORAX PAIN; TOTAL LUNG CAPACITY; WALKING; ADVERSE EFFECTS; BRONCHUS; LUNG RESECTION; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

BRONCHI; BRONCHOSCOPY; HUMANS; PNEUMONECTOMY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85013754433     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD012158.pub2     Document Type: Review

References (178)

1. Come CE, Kramer MR, Dransfield MT, Abu-Hijleh M, Berkowitz D, Bezzi M, et al. A randomised trial of lung sealant versus medical therapy for advanced emphysema. European Respiratory Journal 2015;46(3):651-62. [DOI: 10.1183/09031936.00065715]5281387
2. Davey C, Zoumot Z, Jordan S, Carr DH, Polkey MI, Shah PL, et al. Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi trial): study design and rationale. Thorax 2015;70(3):288-90. [DOI: 10.1136/thoraxjnl-2014-205127]5281389
3. Davey C, Zoumot Z, Jordan S, McNulty WH, Carr DH, Hind MD, et al. Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi study): a randomised controlled trial. Lancet 2015;386(9998):1066-73. [DOI: 10.1016/S0140-6736(15)60001-0]5281390
4. Shah PL, Slebos D-J, Cardoso PFG, Cetti E, Voelker K, Levine B, et al. Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trial. Lancet 2011;378(9795):997-1005. [DOI: 10.1016/S0140-6736(11)61050-7]5281392
5. Shah PL, Slebos D-J, Cardoso PFG, Cetti EJ, Sybrecht GW, Cooper JD. Design of the exhale airway stents for emphysema (EASE) trial: an endoscopic procedure for reducing hyperinflation. BMC Pulmonary Medicine 2011;11(1):1. [DOI: 10.1186/1471-2466-11-1]5281393
6. Eberhardt R, Gompelmann D, Schuhmann M, Reinhardt H, Ernst A, Heussel CP, et al. Complete unilateral vs partial bilateral endoscopic lung volume reduction in patients with bilateral lung emphysema. Chest 2012;142(4):900-8. [DOI: 10.1378/chest.11-2886]5281395
7. Wood DE, Nader DA, Springmeyer SC, Elstad MR, Coxson HO, Chan A, et al. The IBV Valve trial: a multicenter, randomized, double-blind trial of endobronchial therapy for severe emphysema. Journal of Bronchology & Interventional Pulmonology 2014;21(4):288-97. [DOI: 10.1097/LBR.0000000000000110]5281397
8. Valipour A, Slebos D-J, Herth F, Darwiche K, Wagner M, Ficker JH, et al. Endobronchial valve therapy in patients with homogeneous emphysema: results from the IMPACT study. American Journal of Respiratory and Critical Care Medicine 2016;194 (9):1073-82. [DOI: 10.1164/rccm.201607-1383OC]5281399
9. Ninane V, Bezzi M, Geltner C, Gottlieb J, Seijo L, Munavvar M, et al. Non-lobar atelectasis approach for the treatment of advanced emphysema with bronchial valves in a European multicenter, single blinded and randomized study. American Journal of Respiratory and Critical Care Medicine 2010;181:A2847. 5281401
10. Ninane V, Bezzi M, Geltner C, Gottlieb J, Seijo L, Munavvar M, et al. The European multicenter, single blinded and randomized study of bronchial valves for the treatment of advanced emphysema: procedural results.. American Journal of Respiratory and Critical Care Medicine 2010;181:A5164. 5281402
11. Ninane V, Geltner C, Bezzi M, Foccoli P, Gottlieb J, Welte T, et al. Multicentre European study for the treatment of advanced emphysema with bronchial valves. European Respiratory Journal 2012;39(6):1319-25. [DOI: 10.1183/09031936.00019711]5281403
12. Sciurba FC, Criner GJ, Strange C, Shah PL, Michaud G, Connolly TA, et al. Effect of endobronchial coils vs usual care on exercise tolerance in patients with severe emphysema: the RENEW randomized clinical trial. JAMA 2016;315(20):2178-89. [DOI: 10.1001/jama.2016.6261]5281405
13. Shah PL, Zoumot Z, Singh S, Bicknell SR, Ross ET, Quiring J, et al. Endobronchial coils for the treatment of severe emphysema with hyperinflation (RESET): a randomised controlled trial. Lancet Respiratory Medicine 2013;1(3):233-40. [DOI: 10.1016/S2213-2600(13)70047-X]5281407
14. Zoumot Z, Kemp SV, Singh S, Bicknell SR, McNulty WH, Hopkinson NS, et al. Endobronchial coils for severe emphysema are effective up to 12 months following treatment: medium term and cross-over results from a randomised controlled trial. PLOS One 2015;10(4):e0122656. [DOI: 10.1371/journal.pone.0122656]5281408
15. Deslee G, Mal H, Dutau H, Bourdin A, Vergnon JM, Pison C, et al. Lung volume reduction coil treatment vs usual care in patients with severe emphysema: the REVOLENS randomized clinical trial. JAMA 2016;315(2):175-84. [DOI: 10.1001/jama.2015.17821]5281410
16. Hartman JE, Klooster K, Slebos D-J, Ten Hacken NHT. Improvement of physical activity after endobronchial valve treatment in emphysema patients. Respiratory Medicine 2016;117:116-21. [DOI: 10.1016/j.rmed.2016.06.009]5281412
17. Klooster K, Ten Hacken NHT, Hartman JE, Kerstjens HAM, Van Rikxoort EM, Slebos D-J. Endobronchial valves for emphysema without interlobar collateral ventilation. New England Journal of Medicine 2015;373(24):2325-35. [DOI: 10.1056/NEJMoa1507807]5281413
18. Bandyopadhyay S, Henne E, Gupta A, Barry R, Snell G, Strange C, et al. Segmental approach to lung volume reduction therapy for emphysema patients. Respiration 2014;89(1):76-81. [DOI: 10.1159/000369036]5281415
19. Herth FJF, Valipour A, Shah PL, Eberhardt R, Grah C, Egan J, et al. Segmental volume reduction using thermal vapour ablation in patients with severe emphysema: 6-month results of the multicentre, parallel-group, open-label, randomised controlled STEP-UP trial. Lancet Respiratory Medicine 2016;4(3):185-93. [DOI: 10.1016/S2213-2600(16)00045-X]5281416
20. Valipour A, Herth FJF, Eberhardt R, Shah PL, Gupta A, Barry R, et al. Design of the randomized, controlled sequential staged treatment of emphysema with upper lobe predominance (STEP-UP) study. BMC Pulmonary Medicine 2014;14(1):1. [DOI: 10.1186/1471-2466-14-190]5281417
21. Herth FJF, Noppen M, Valipour A, Leroy S, Vergnon J-M, Ficker JH, et al. Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort. European Respiratory Journal 2012;39(6):1334-42. [DOI: 10.1183/09031936.00161611]5281419
22. Pietzsch JB, Garner A, Herth FJF. Cost-effectiveness of endobronchial valve therapy for severe emphysema: a model-based projection based on the VENT study. Respiration 2014;88(5):389-98. [DOI: 10.1159/000368088]5281420
23. Argula RG, Strange C, Ramakrishnan V, Goldin J. Baseline regional perfusion impacts exercise response to endobronchial valve therapy in advanced pulmonary emphysema. Chest 2013;144(5):1578-86. 5281422
24. Brown MS, Kim HJ, Abtin FG, Strange C, Galperin-Aizenberg M, Pais R, et al. Emphysema lung lobe volume reduction: effects on the ipsilateral and contralateral lobes. European Radiology 2012;22(7):1547-55. 5281423
25. Eberhardt R, Herth FJF, Radhakrishnan S, Gompelmann D. Comparing clinical outcomes in upper versus lower lobe endobronchial valve treatment in severe emphysema. Respiration 2015;90(4):314-20. 5281424
26. Liberator C, Shenoy K, Marchetti N, Criner G. The role of lobe selection on FEV1 response in endobronchial valve therapy. Journal of Chronic Obstructive Pulmonary Disease 2016;13(4):1-6. 5281425
27. Pietzsch JB, Garner A, Herth FJF. Cost-effectiveness of endobronchial valve therapy for severe emphysema: a model-based projection based on the VENT study. Respiration 2014;88(5):389-98. [DOI: 10.1159/000368088]5281426
28. Sciurba FC, Ernst A, Herth FJF, Strange C, Criner GJ, Marquette CH, et al. A randomized study of endobronchial valves for advanced emphysema. New England Journal of Medicine 2010;363(13):1233-44. 5281427
29. Strange C, Herth FJF, Kovitz KL, McLennan G, Ernst A, Goldin J, et al. Design of the endobronchial valve for emphysema palliation trial (VENT): a non-surgical method of lung volume reduction. BMC Pulomonary Medicine 2007;7(10):1. 5281428
30. Valipour A, Herth FJF, Burghuber OC, Criner G, Vergnon J-M, Goldin J, et al. Target lobe volume reduction and COPD outcome measures after endobronchial valve therapy. European Respiratory Journal 2014;43(2):387-96. 5281429
31. Abumossalam AM, El-Halaby HA, Abd El-khalek AM. Poor man medical pneumoplasty: bronchoscopic lung volume reduction with hot saline versus dissolved doxycycline as a neoteric remedy of pulmonary emphysema. Egyptian Journal of Chest Diseases and Tuberculosis 2016;65(1):71-9. 5281431
32. Cardoso PFG, Snell GI, Hopkins P, Sybrecht GW, Stamatis G, Ng AW, et al. Clinical application of airway bypass with paclitaxel-eluting stents: early results. Journal of Thoracic and Cardiovascular Surgery 2007;134(4):974-81. 5281433
33. Choong CK, Haddad FJ, Gee EY, Cooper JD. Feasibility and safety of airway bypass stent placement and influence of topical mitomycin C on stent patency. Journal of Thoracic and Cardiovascular Surgery 2005;129(3):632-8. 5281435
34. Choong CK, Phan L, Massetti P, Haddad FJ, Martinez C, Roschak E, et al. Prolongation of patency of airway bypass stents with use of drug-eluting stents. Journal of Thoracic and Cardiovascular Surgery 2006;131(1):60-4. 5281437
35. Choong CK, Macklem PT, Pierce JA, Das N, Lutey BA, Martinez CO, et al. Airway bypass improves the mechanical properties of explanted emphysematous lungs. American Journal of Respiratory and Critical Care Medicine 2008;178(9):902-5. 5281439
36. Criner GJ, Pinto-Plata V, Strange C, Dransfield M, Gotfried M, Leeds W, et al. Biologic lung volume reduction in advanced upper lobe emphysema: phase 2 results. American Journal of Respiratory and Critical Care Medicine 2009;179(9):791-8. [DOI: 10.1164/rccm.200810-1639OC]5281441
37. De Oliveira HG, Macedo-Neto AV, John AB, Jungblut S, Prolla JC, Menna-Barreto SS, et al. Transbronchoscopic pulmonary emphysema treatment: 1-month to 24-month endoscopic follow-up. Chest 2006;130(1):190-9. 5281443
38. Deslee G, Klooster K, Hetzel M, Stanzel F, Kessler R, Marquette CH, et al. Lung volume reduction coil treatment for patients with severe emphysema: a European multicentre trial. Thorax 2014;69(11):980-6. 5281445
39. Emery MJ, Eveland RL, Eveland K, Couetil LL, Hildebrandt J, Swenson ER. Lung volume reduction by bronchoscopic administration of steam. American Journal of Respiratory and Critical Care Medicine 2010;182(10):1282-91. 5281447
40. Faisal A, Zoumot Z, Shah PL, Neder JA, Polkey MI, Hopkinson NS. Effective bronchoscopic lung volume reduction accelerates exercise oxygen uptake kinetics in emphysema. Chest 2016;149(2):435-46. 5281449
41. Falkenstern-Ge RF, Ingerl H, Kohlhäufl M. Severe emphysema treated by endoscopic bronchial volume reduction with lung sealant (AeriSeal). Case Reports in Pulmonology 2013;2013:.. [DOI: 10.1155/2013/361391]5281451
42. Fann JI, Berry GJ, Burdon TA. Bronchoscopic approach to lung volume reduction using a valve device. Journal of Bronchology and Interventional Pulmonology 2003;10(4):253-9. 5281453
43. Fruchter O, Rosengarten D, Goldberg E, Ben-Zvi H, Tor R, Kramer MR. Airway bacterial colonization and serum C-reactive protein are associated with chronic obstructive pulmonary disease exacerbation following bronchoscopic lung volume reduction. Clinical Respiratory Journal 2016;10(2):239-45. [DOI: 10.1111/crj.12211]5281455
44. Gompelmann D, Eberhardt R, Michaud G, Ernst A, Herth FJ. Predicting atelectasis by assessment of collateral ventilation prior to endobronchial lung volume reduction: a feasibility study. Respiration 2010;80(5):419-25. 5281457
45. Gompelmann D, Heussel CP, Eberhardt R, Snell G, Hopkins P, Baker K, et al. Efficacy of bronchoscopic thermal vapor ablation and lobar fissure completeness in patients with heterogeneous emphysema. Respiration 2012;83(5):400-6. [DOI: 10.1159/000336239]5281459
46. Gompelmann D, Eberhardt R, Ernst A, Hopkins P, Egan J, Stanzel F, et al. The localized inflammatory response to bronchoscopic thermal vapor ablation. Respiration 2013;86(4):324-31. [DOI: 10.1159/000354175]5281461
47. Hartman JE, Klooster K, Gortzak K, Ten Hacken NH, Slebos DJ. Long-term follow-up after bronchoscopic lung volume reduction treatment with coils in patients with severe emphysema. Respirology 2015;20(2):319-26. 5281463
48. Herth FJF, Eberhard R, Gompelmann D, Slebos D-J, Ernst A. Bronchoscopic lung volume reduction with a dedicated coil: a clinical pilot study. Therapeutic Advances in Respiratory Disease 2010;4(4):225-31. [DOI: 10.1177/1753465810368553]5281465
49. Herth FJF, Gompelmann D, Stanzel F, Bonnet R, Behr J, Schmidt B, et al. Treatment of advanced emphysema with emphysematous lung sealant (AeriSeal). Respiration 2011;82(1):36-45. [DOI: 10.1159/000322649]5281467
50. Herth FJ, Ernst A, Baker KM, Egan JJ, Gotfried MH, Hopkins P, et al. Characterization of outcomes 1 year after endoscopic thermal vapor ablation for patients with heterogeneous emphysema. International Journal of Chronic Obstructive Pulmonary Disease 2012;7:397-405. 5281469
51. Hopkinson NS, Toma TP, Hansell DM, Goldstraw P, Moxham J, Geddes DM, et al. Effect of bronchoscopic lung volume reduction on dynamic hyperinflation and exercise in emphysema. American Journal of Respiratory Critical Care Medicine 2005;171(5):453-60. 5281471
52. Hopkinson NS, Kemp SV, Toma TP, Hansell DM, Geddes DM, Shah PL, et al. Atelectasis and survival after bronchoscopic lung volume reduction for COPD. European Respiratory Journal 2011;37(6):1346-51. 5281473
53. Klooster K, Ten Hacken NHT, Franz I, Kerstjens HAM, Van Rikxoort EM, Slebos D-J. Lung volume reduction coil treatment in chronic obstructive pulmonary disease patients with homogeneous emphysema: a prospective feasibility trial. Respiration 2014;88(2):116-25. [DOI: 10.1159/000362522]5281475
54. Kontogianni K, Gerovasili V, Gompelmann D, Schuhmann M, Heussel CP, Herth FJ, et al. Effectiveness of endobronchial coil treatment for lung volume reduction in patients with severe heterogeneous emphysema and bilateral incomplete fissures: a six-month follow-up. Respiration 2014;88(1):52-60. 5281477
55. Kotecha S, Westall GP, Holsworth L, Pham A, Williams TJ, Snell GI. Long-term outcomes from bronchoscopic lung volume reduction using a bronchial prosthesis. Respirology 2011;16(1):167-73. 5281479
56. Kramer MR, Refaely Y, Maimon N, Rosengarten D, Fruchter O. Bilateral endoscopic sealant lung volume reduction therapy for advanced emphysema. Chest 2012;142(5):1111-7. 5281481
57. Kramer MR, Refaely Y, Maimon N, Rosengarten D, Fruchter O. Two-year follow-up in patients treated with emphysematous lung sealant for advanced emphysema. Chest 2013;144(5):1677-80. [DOI: 10.1378/chest.13-0446.]5281482
58. Kramer MR, Fruchter O, Eberhardt R, Valipour A, Assadi S, Bonnet R, et al. Emphysematous lung sealant therapy attenuates the chronic inflammatory state of advanced emphysema. Journal of Pulmonary & Respiratory Medicine 2013;3(5):1-5. [DOI: 10.4172/2161-105X.1000163]5281484
59. Magnussen H, Kramer MR, Kirsten AM, Marquette C, Valipour A, Stanzel F, et al. Effect of fissure integrity on lung volume reduction using a polymer sealant in advanced emphysema. Thorax 2012;67(4):302-8. 5281486
60. Pizarro C, Ahmadzadehfar H, Essler M, Tuleta I, Fimmers R, Nickenig G, et al. Effect of endobronchial valve therapy on pulmonary perfusion and ventilation distribution. PLOS One 2015;10(3):e0118976. 5281488
61. Refaely Y, Dransfield M, Kramer MR, Gotfried M, Leeds W, McLennan G, et al. Biologic lung volume reduction therapy for advanced homogeneous emphysema. European Respiratory Journal 2010;36(1):20-7. 5281490
62. Reilly J, Washko G, Pinto-Plata V, Velez E, Kenney L, Berger R, et al. Biological lung volume reduction: a new bronchoscopic therapy for advanced emphysema. Chest 2007;131(4):1108-13. 5281492
63. Rendina EA, De Giacomo T, Venuta F, Coloni GF, Meyers BF, Patterson GA, et al. Feasibility and safety of the airway bypass procedure for patients with emphysema. Journal of Thoracic and Cardiovascular Surgery 2003;125(6):1294-7. 5281494
64. Slebos DJ, Klooster K, Ernst A, Herth FJ, Kerstjens HA. Bronchoscopic lung volume reduction coil treatment of patients with severe heterogeneous emphysema. Chest 2012;142(3):574-82. 5281496
65. Snell GI, Holsworth L, Borrill ZL, Thomson KR, Kalff V, Smith JA, et al. The potential for bronchoscopic lung volume reduction using bronchial prostheses. Chest 2003;124(3):1073-80. 5281498
66. Snell GI, Hopkins P, Westall G, Holsworth L, Carle A, Williams TJ. A feasibility and safety study of bronchoscopic thermal vapor ablation: a novel emphysema therapy. Annals of Thoracic Surgery 2009;88(6):1993-8. 5281500
67. Snell G, Herth FJ, Hopkins P, Baker KM, Witt C, Gotfried MH, et al. Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema. European Respiratory Journal 2012;39(6):1326-33. 5281502
68. Springmeyer SC, Bolliger CT, Waddell TK, Gonzalez X, Wood DE, Teams IBVVPTR. Treatment of heterogeneous emphysema using the Spiration IBV valves. Thoracic Surgery Clinics 2009;19(2):247-53, ix-x. 5281504
69. Toma TP, Hopkinson NS, Hillier J, Hansell DM, Morgan C, Goldstraw PG, et al. Bronchoscopic volume reduction with valve implants in patients with severe emphysema. Lancet 2003;361(9361):931-3. 5281506
70. Venuta F, Anile M, Diso D, Carillo C, De Giacomo T, D'Andrilli A, et al. Long-term follow-up after bronchoscopic lung volume reduction in patients with emphysema. European Respiratory Journal 2012;39(5):1084-9. 5281508
71. Venuta F, De Giacomo T, Rendina EA, Ciccone AM, Diso D, Perrone A, et al. Bronchoscopic lung-volume reduction with one-way valves in patients with heterogenous emphysema. Annals of Thoracic Surgery 2005;79(2):411-6; discussion 6-7. 5281509
72. Venuta F, Diso D, Anile M, De Giacomo T, Rendina EA, Rolla M, et al. Bronchoscopic lung volume reduction as a bridge to lung transplantation in patients with chronic obstructive pulmonary disease. European Journal Cardio-Thoracic Surgery 2011;39(3):364-7. [DOI: 10.1016/j.ejcts.2010.06.005]5281511
73. Wan IY, Toma TP, Geddes DM, Snell G, Williams T, Venuta F, et al. Bronchoscopic lung volume reduction for end-stage emphysema: report on the first 98 patients. Chest 2006;129(3):518-26. 5281513
74. Wood DE, McKenna RJ, Yusen RD, Sterman DH, Ost DE, Springmeyer SC, et al. A multicenter trial of an intrabronchial valve for treatment of severe emphysema. Journal of Thoracic and Cardiovascular Surgery 2007;133(1):65-73. [DOI: 10.1016/j.jtcvs.2006.06.051]5281515
75. Yim AP, Hwong TM, Lee TW, Li WW, Lam S, Yeung TK, et al. Early results of endoscopic lung volume reduction for emphysema. Journal of Thoracic and Cardiovascular Surgery 2004;127(6):1564-73. 5281517
76. ISRCTN19684749 . The CELEB trial: comparative effectiveness of lung volume reduction surgery for emphysema and bronchoscopic lung volume reduction with valve placement. www.isrctn.com/ISRCTN19684749 (accessed 23 May 2016). 5281519
77. NCT01457833 . Implantation of endobronchial valves versus intrabronchial valves in patients with severe heterogeneous emphysema. clinicaltrials.gov/ct2/show/NCT01457833 (accessed 19 October 2011). 5281521
78. NCT01796392 . Pulmonx endobronchial valves used in treatment of emphysema (LIBERATE Study). clinicaltrials.gov/ct2/show/record/NCT01796392 (accessed 20 February 2013). 5281523
79. NCT01812447 . Evaluation of the Spiration® Valve System for Emphysema to Improve Lung Function (EMPROVE). clinicaltrials.gov/ct2/show/record/NCT01812447 (accessed 7 March 2013). 5281525
80. Li S, Wang G, Wang C, Jin F, Gao X, Yang H, et al. LATE-BREAKING ABSTRACT: The REACH study, a randomized controlled trial assessing the safety and effectiveness of the spiration valve system intra-bronchial therapy for severe emphysema. European Respiratory Journal 2016;48:OA3013. 5281527
81. NCT01989182 . The spiration valve system for the treatment of severe emphysema. clinicaltrials.gov/ct2/show/record/NCT01989182 (accessed 6 November 2013). 5281528
82. NCT02022683 . To improve lung function and symptoms for emphysema patients Using Zephyr EBV (TRANSFORM). clinicaltrials.gov/ct2/show/record/NCT02022683 (accessed 17 December 2013). 5281530
83. NCT02823223 . Endobronchial valve in patients With heterogeneous emphysema. clinicaltrials.gov/ct2/show/record/NCT02823223 (accessed 29 June 2016). 5281532
84. Agzarian J, Miller JD, Kosa SD, Malthaner R, Tan L, Canadian Volume Reduction Surgery Study Group. Long-term survival analysis of the Canadian lung volume reduction surgery trial. Annals of Thoracic Surgery 2013;96(4):1217-22. [DOI: 10.1016/j.athoracsur.2013.04.077.]
85. Aljuri N, Freitag L. Validation and pilot clinical study of a new bronchoscopic method to measure collateral ventilation before endobronchial lung volume reduction. Applied Physiology 2009;106(3):774-83. [DOI: 10.3109/15412555.2015.1115007]
86. Ambrosino N. Field tests in pulmonary disease. Thorax 1999;54(3):191-3. [DOI: 10.1136/thx.54.3.191]
87. Bagdonas E, Raudoniute J, Bruzauskaite I, Aldonyte R. Novel aspects of pathogenesis and regeneration mechanisms in COPD. International Journal of Chronic Obstructive Pulmonary Disease 2015;10:995-1013. [DOI: 10.2147/COPD.S82518]
88. Biederer J, Beer M, Hirsch W, Wild J, Fabel M, Puderbach M, et al. MRI of the lung (2/3). Why... when ... how?. Insights Imaging 2012;3(4):355-71. [DOI: 10.1007/s13244-011-0146-8]
89. Bourdin A, Burgel PR, Chanez P, Garcia G, Perez T, Roche N. Recent advances in COPD: pathophysiology, respiratory physiology and clinical aspects, including comorbidities. European Respiratory Review 2009;18(114):198-212. [DOI: 10.1183/09059180.00005509]
90. Boutou AK, Shrikrishna D, Tanner RJ, Smith C, Kelly JL, Ward SP, et al. Lung function indices for predicting mortality in COPD. European Respiratory Journal 2013;42(3):616-25. [DOI: 10.1183/09031936.00146012]
91. Boutou AK, Zoumot Z, Nair A, Davey C, Hansell DM, Jamurtas A, et al. The impact of homogeneous versus heterogeneous emphysema on dynamic hyperinflation in patients with severe COPD assessed for lung volume reduction. Journal of Chronic Obstructive Pulmonary Disease 2015;12(6):598-605. [DOI: 10.3109/15412555.2015.1020149]
92. Campbell M, Grimshaw J, Steen N. Sample size calculations for cluster randomised trials. Journal of Health Services Research & Policy 2000;5(1):12-16.
93. Cavaillès A, Brinchault-Rabin G, Dixmier A, Goupil F, Gut-Gobert C, Marchand-Adam S, et al. Comorbidities of COPD. European Respiratory Review 2013;22(130):454-75. [DOI: 10.1183/09059180.00008612]
94. Cazzola M, MacNee W, Martinez FJ, Rabe Klaus F, Franciosi LG, Barnes PJ, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. European Respiratory Journal 2008;31(2):416-69. [DOI: 10.1183/09031936.00099306]
95. Celli BR, Barnes PJ. Exacerbations of chronic obstructive pulmonary disease. European Respiratory Journal 2007;29(6):1224-38. [DOI: 10.1183/09031936.00109906]
96. Cetti EJ, Moore AJ, Geddes DM. Collateral ventilation. Thorax 2006;61(5):371-3. [DOI: 10.1136/thx.2006.060509]
97. Clark SJ, Zoumot Z, Bamsey O, Polkey MI, Dusmet M, Lim E, et al. Surgical approaches for lung volume reduction in emphysema. Clinical Medicine 2014;14(2):122-7. [DOI: 10.7861/clinmedicine.]
98. Cooper JD, Trulock EP, Triantafillou AN, Patterson GA, Pohl MS, Deloney RN, et al. Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. Journal of Thoracic and Cardiovascular Surgery 1995;109(1):106-19.
99. Cooper JD. "All that glitters": evaluating interventions for emphysema. Chest 2010;138(2):243-5.
100. Criner GJ, Sternberg AL. National Emphysema Treatment Trial: the major outcomes of lung volume reduction surgery in severe emphysema. Proceedings of the American Thoracic Society 2008;5(4):393-405. [DOI: 10.1513/pats.200801-013ET]
101. Criner GJ, Cordova F, Sternberg AL, Martinez FJ. The National Emphysema Treatment Trial (NETT) part II: lessons learned about lung volume reduction surgery. American Journal of Respiratory and Critical Care Medicine 2011;184(8):881-93.
102. Dal Negro R. Optimizing economic outcomes in the management of COPD. International Journal of Chronic Obstructive Pulmonary Disease 2008;3(1):1-10. [PUBMED: PMC2528207]
103. Demedts IK, Demoor T, Bracke KR, Joos GF, Brusselle GG. Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respiratory Research 2006;7(1):53. [DOI: 10.1186/1465-9921-7-53]
104. Donohue JF. Minimal clinically important differences in COPD lung function. COPD 2005;2(1):111-24.
105. Eberhardt R, Gompelmann D, Herth FJF, Schuhmann M. Endoscopic bronchial valve treatment: patient selection and special considerations. International Journal of Chronic Obstructive Pulmonary Disease 2015;10:2147. [DOI: 10.2147/COPD.S63473]
106. Ferguson GT. Why does the lung hyperinflate?. Proceedings of the American Thoracic Society 2006;3(2):176-9. [DOI: 10.1513/pats.200508-094DO]
107. Fessler HE, Permutt S. Lung volume reduction surgery and airflow limitation. American Journal of Respiratory and Critical Care Medicine 1998;157(3):715-22. [DOI: /10.1164/ajrccm.157.3.9608004]
108. Fessler HE, Scharf SM, Permutt S. Improvement in spirometry following lung volume reduction surgery: application of a physiologic model. American Journal of Respiratory and Critical Care Medicine 2002;165(1):34-40.
109. Fessler HE. Collateral ventilation, the bane of bronchoscopic volume reduction. American Journal of Respiratory and Critical Care Medicine 2005;171(5):423-4.
110. Fessler HE, Scharf SM, Ingenito EP, McKenna RJ Jr, Sharafkhaneh A. Physiologic basis for improved pulmonary function after lung volume reduction. Proceedings of the American Thoracic Society 2008;5(4):416-20. [DOI: 10.1513/pats.200708-117ET]
111. Galluccio G, Lucantoni G. Bronchoscopic lung volume reduction for pulmonary emphysema: preliminary experience with a new NOVATECHÂ endobronchial silicone one-way valve. Interactive CardioVascular and Thoracic Surgery 2010;11(2):213-5. [DOI: 10.1510/icvts.2010.236398]
112. Garner J, Kemp SV, Toma TP, Hansell DM, Polkey MI, Shah PL, et al. Survival after endobronchial valve placement for emphysema: a 10-year follow-up study. American Journal of Respiratory and Critical Care Medicine 2016;194(4):519-21.
113. Ginsburg ME, Thomashow BM, Yip CK, DiMango AM, Maxfield RA, Bartels MN, et al. Lung volume reduction surgery using the NETT selection criteria. Annals of Thoracic Surgery 2011;91(5):1556-61. [DOI: 10.1016/j.athoracsur.2011.01.054]
114. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD. http://www.goldcopd.org/ (accessed 2 February 2016).
115. Gompelmann D, Herth FJF, Slebos DJ, Valipour A, Ernst A, Criner GJ, et al. Pneumothorax following endobronchial valve therapy and its impact on clinical outcomes in severe emphysema. Respiration 2014;87(6):485-91.
116. Gompelmann D, Eberhardt R, Herth F. Endoscopic volume reduction in COPD - a critical review. Deutsches Ärzteblatt International 2014;111(49):827-33.
117. GRADE Working Group, McMaster University. GRADEpro GDT. Version accessed 2 February 2016. Hamilton (ON): GRADE Working Group, McMaster University, 2014.
118. Hartman JE, Ten Hacken NHT, Klooster K, Boezen HM, De Greef MHG, Slebos D-J. The minimal important difference for residual volume in patients with severe emphysema. European Respiratory Journal 2012;40(5):1137-41. [DOI: 10.1183/09031936.00219111]
119. Herth FJF, Eberhardt R, Gompelmann D, Ficker JH, Wagner M, Ek L, et al. Radiological and clinical outcomes of using Chartis to plan endobronchial valve treatment. European Respiratory Journal 2013;41(2):302-8.
120. Herth FJF, Slebos D-J, Rabe KF, Shah PL. Endoscopic lung volume reduction: an expert panel recommendation. Respiration 2016;91(3):241-50. [DOI: 10.1159/000444090]
121. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 (updated March 2011). The Cochrane Collaboration, 2011. available from www.handbook.cochrane.org.
122. Higuchi T, Reed A, Oto T, Holsworth L, Ellis S, Bailey MJ, et al. Relation of interlobar collaterals to radiological heterogeneity in severe emphysema. Thorax 2006;61(5):409-13. [DOI: 10.1136/thx.2005.051219]
123. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004;364(9435):709-21.
124. Ingenito EP, Reilly JJ, Mentzer SJ, Swanson SJ, Vin R, Keuhn H, et al. Bronchoscopic volume reduction: a safe and effective alternative to surgical therapy for emphysema. American Journal of Respiratory and Critical Care Medicine 2001;164(2):295-301.
125. Ingenito EP, Tsai LW, Majumdar A, Suki B. On the role of surface tension in the pathophysiology of emphysema. American Journal of Respiratory and Critical Care Medicine 2005;171(4):300-4. [DOI: 10.1164/rccm.200406-770PP]
126. Ingenito EP, Wood DE, Utz JP. Bronchoscopic lung volume reduction in severe emphysema. Proceedings of the American Thoracic Society 2008;5(4):454-60. [DOI: 10.1513/pats.200707-085ET]
127. Jones PW. St. George's respiratory questionnaire: MCID. COPD 2005;2(1):75-9.
128. Kim V, Rogers TJ, Criner GJ. New concepts in the pathobiology of chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society 2008;5(4):478-85. [PUBMED: 18453359]
129. Kirkham PA, Barnes PJ. Oxidative stress in COPD. Chest 2013;144(1):266-73. [DOI: 10.1378/chest.12-2664]
130. Klooster K, Ten Hacken NHT, Slebos D-J. The lung volume reduction coil for the treatment of emphysema: a new therapy in development. Expert Review of Medical Devices 2014;11(5):481-9. [DOI: 10.1586/17434440.2014.929490]
131. Koster TD, Slebos D-J. The fissure: interlobar collateral ventilation and implications for endoscopic therapy in emphysema. International Journal of Chronic Obstructive Pulmonary Disease 2016;11:765. [DOI: 10.2147/COPD.S103807]
132. Lausberg HF, Chino K, Patterson GA, Meyers BF, Toeniskoetter PD, Cooper JD. Bronchial fenestration improves expiratory flow in emphysematous human lungs. Annals of Thoracic Surgery 2003;75(2):393-8.
133. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2013;380(9859):2095-128. [DOI: 10.1016/S0140-6736(12)61728-0]
134. Macklin R. The ethical problems with sham surgery in clinical research. New England Journal of Medicine 1999;341(13):992-6. [DOI: 10.1056/NEJM199909233411312]
135. Mair G, Miller JJ, McAllister D, Maclay J, Connell M, Murchison JT, et al. Computed tomographic emphysema distribution: relationship to clinical features in a cohort of smokers. European Respiratory Journal 2009;33(3):536-42. [DOI: 10.1183/09031936.00111808]
136. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007;370(9589):765-73. [DOI: 10.1016/S0140-6736(07)61380-4]
137. Mannino DM, Braman S. The epidemiology and economics of chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society 2007;4(7):502-6. [DOI: 10.1513/pats.200701-001FM]
138. Maxfield RA. New and emerging minimally invasive techniques for lung volume reduction. Chest 2004;125(2):777-83.
139. McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2015, Issue 2. [DOI: 10.1002/14651858.CD003793.pub3]
140. McNulty W, Jordan S, Hopkinson NS. Attitudes and access to lung volume reduction surgery for COPD: a survey by the British Thoracic Society. BMJ Open Respiratory Research 2014;1(1):e000023. [DOI: 10.1136/bmjresp-2014-000023]
141. Milanese G, Silva M, Sverzellati N. Lung volume reduction of pulmonary emphysema: the radiologist task. Current Opinion in Pulmonary Medicine 2016;22(2):179-86. [DOI: 10.1097/MCP.0000000000000252]
142. Miller FG, Kaptchuk TJ. Sham procedures and the ethics of clinical trials. Journal of the Royal Society of Medicine 2004;97(12):576-8.
143. Miller JD, Malthaner RA, Goldsmith CH, Goeree R, Higgins D, Cox PG, et al. A randomized clinical trial of lung volume reduction surgery versus best medical care for patients with advanced emphysema: a two-year study from Canada. Annals of Thoracic Surgery 2006;81(1):314-21. [PUBMED: 16368389]
144. Moher D, Liberati A, Tetzlaff J, Altman D. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLOS Medicine 2009;6(7):e1000097. [DOI: 10.1371/journal.pmed.1000097]
145. Mura M, Zompatori M, Mussoni A, Fasano L, Pacilli AMG, Ferro O, et al. Bullous emphysema versus diffuse emphysema: a functional and radiologic comparison. Respiratory Medicine 2005;99(2):171-8. [DOI: 10.1016/j.rmed.2004.06.010]
146. Naunheim KS, Wood DE, Mohsenifar Z, Sternberg AL, Criner GJ, DeCamp MM, et al. Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Annals of Thoracic Surgery 2006;82(2):431-43.
147. National Emphysema Treatment Trial Research Group. Patients at high risk of death after lung-volume-reduction surgery. New England Journal of Medicine 2001;345(15):1075. [DOI: 10.1056/NEJMoa11798]
148. The National Institute for Health and Care Excellence. Chronic obstructive pulmonary disease in over 16s: diagnosis and management. https://www.nice.org.uk/guidance/cg101 (accessed 15 April 2016).
149. Papandrinopoulou D, Tzouda V, Tsoukalas G. Lung compliance and chronic obstructive pulmonary disease. Pulmonary Medicine 2012;2012:1-6. [DOI: 10.1155/2012/542769]
150. Park TS, Hong Yi, Lee JS, Oh SY, Lee SM, Kim N, et al. Bronchoscopic lung volume reduction by endobronchial valve in advanced emphysema: the first Asian report. International Journal of Chronic Obstructive Pulmonary Disease 2015;10:1501. [DOI: 10.2147/COPD.S85744]
151. Perera PN, Armstrong EP, Sherrill DL, Skrepnek GH. Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality. Journal of Chronic Obstructive Pulmomary Disease 2012;9(2):131-41. [DOI: 10.3109/15412555.2011.650239]
152. Pompeo E, Rogliani P, Tacconi F, Dauri M, Saltini C, Novelli G, et al. Randomized comparison of awake nonresectional versus nonawake resectional lung volume reduction surgery. Journal of Thoracic and Cardiovascular Surgery 2012;143(1):47-54. [DOI: 10.1016/j.jtcvs.2011.09.050.]
153. Puhan MA, Gimeno-Santos E, Scharplatz M, Troosters T, Walters EH, Steurer J. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2011, Issue 10. [DOI: 10.1002/14651858.CD005305.pub3]
154. Puhan MA, Chandra D, Mosenifar Z, Ries A, Make B, Hansel NN, et al. The minimal important difference of exercise tests in severe COPD. European Respiratory Journal 2011;37(4):784-90. [DOI: 10.1183/09031936.00063810.]
155. Ramsey SD, Shroyer AL, Sullivan SD, Wood DE. Updated evaluation of the cost-effectiveness of lung volume reduction surgery. Chest 2007;131(3):823-32.
156. Rathinam S, Oey I, Steiner M, Spyt T, Morgan MD, Waller DA. The role of the emphysema multidisciplinary team in a successful lung volume reduction surgery programme. European Journal of Cardio-Thoracic Surgery 2014;46(6):1021-6.
157. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
158. Schuhmann M, Raffy P, Yin Y, Gompelmann D, Oguz I, Eberhardt R, et al. Computed tomography predictors of response to endobronchial valve lung reduction treatment. Comparison with Chartis. American Journal of Respiratory and Critical Care Medicine 2015;191(7):767-74.
159. Shah PL, Herth FJF. Current status of bronchoscopic lung volume reduction with endobronchial valves. Thorax 2014;69(3):280-6.
160. Sharafkhaneh A, Hanania NA, Kim V. Pathogenesis of emphysema: from the bench to the bedside. Proceedings of the American Thoracic Society 2008;5(4):475-7. [DOI: 10.1513/pats.200708-126ET]
161. Stockley RA, Mannino D, Barnes PJ. Burden and pathogenesis of chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society 2009;6(6):524-6. [DOI: 10.1513/pats.200904-016DS]
162. Storbeck B, Schröder TH, Oldigs M, Rabe KF, Weber C. Emphysema: imaging for endoscopic lung volume reduction [Lungenemphysem: Bildgebung bei endoskopischerLungenvolumenreduktion]. Fortschritte auf dem Gebiet der Röntgenstrahlen und bildgebenden Verfahren 2015;187:543-54. [DOI: 10.1055/s-0034-1399424]
163. Suki B, Lutchen KR, Ingenito EP. On the progressive nature of emphysema: roles of proteases, inflammation, and mechanical forces. American Journal of Respiratory and Critical Care Medicine 2003;168(5):516-21. [DOI: 10.1164/rccm.200208-908PP]
164. Taraseviciene-Stewart L, Voelkel NF. Molecular pathogenesis of emphysema. Journal of Clinical Investigation 2008;118(2):394-402. [DOI: 10.1172/JCI31811]
165. Terry PB, Traystman RJ, Newball HH, Batra G, Menkes HA. Collateral ventilation in man. New England Journal of Medicine 1978;298(1):10-15.
166. Tuder RM, McGrath S, Neptune E. The pathobiological mechanisms of emphysema models: what do they have in common?. Pulmonary Pharmacology and Therapeutics 2003;16(2):67-78.
167. Valipour A, Shah PL, Gesierich W, Eberhardt R, Snell G, Strange C, et al. Patterns of emphysema heterogeneity. Respiration 2015;90(5):402-11.
168. Van Agteren JEM, Carson, KV, Tiong LU, Smith BJ. Lung volume reduction surgery for diffuse emphysema. Cochrane Database of Systematic Reviews 2016, Issue 10. [DOI: 10.1002/14651858.CD001001.pub3; CD001001]
169. Venuta F, Rendina EA, De Giacomo T, Anile M, Diso D, Andreetti C, et al. Bronchoscopic procedures for emphysema treatment. European Journal of Cardio-thoracic Surgery 2006;29(3):281-7. [DOI: 10.1016/j.ejcts.2005.12.009]
170. Weder W, Thurnheer R, Stammberger U, Bürge M, Russi EW, Bloch KE. Radiologic emphysema morphology is associated with outcome after surgical lung volume reduction. Annals of Thoracic Surgery 1997;64(2):313-20.
171. Weder W, Tutic M, Bloch KE. Lung volume reduction surgery in nonheterogeneous emphysema. Thoracic Surgery Clinics 2009;19(2):193-9. [DOI: 10.1016/j.thorsurg.2009.03.002]
172. Wedzicha JA, Donaldson GC. Exacerbations of chronic obstructive pulmonary disease. Respiratory Care 2003;48(12):1204-15.
173. Wedzicha JA, Decramer M, Seemungal TAR. The role of bronchodilator treatment in the prevention of exacerbations of COPD. European Respiratory Journal 2012;40(6):1545-54. [DOI: 10.1183/09031936.00048912]
174. Welling JBA, Hartman JE, Ten Hacken NHT, Klooster K, Slebos D-J. The minimal important difference for the St George's Respiratory Questionnaire in patients with severe COPD. European Respiratory Journal 2015;46(6):1598-604. [DOI: 10.1183/13993003.00535-20151]
175. Welte T, Vogelmeier C, Papi A. COPD: early diagnosis and treatment to slow disease progression. International Journal of Clinical Practice 2015;69(3):336-49. [DOI: 10.1111/ijcp.12522]
176. Zeng G, Sun B, Zhong N. Non-smoking-related chronic obstructive pulmonary disease: A neglected entity?. Respirology 2012;17(6):908-12. [DOI: 10.1111/j.1440-1843.2012.02152.x.]
177. Zoumot Z, Jordan S, Hopkinson NS. Emphysema: time to say farewell to therapeutic nihilism. Thorax 2014;69(11):973-5. [DOI: 10.1136/thoraxjnl-2014-205667]
178. Zoumot Z, LoMauro A, Aliverti A, Nelson C, Ward S, Jordan S, et al. Lung volume reduction in emphysema improves chest wall asynchrony. Chest 2015;148(1):185-95. [DOI: 10.1378/chest.14-2380]